|
|
Biotech
|
|
||
Re: Snips & notes$RGNX PT Lowered to $55 at Morgan Stanley $SRPT PT Raised to $182 at Morgan Stanley $BLUE Morgan Stanley Maintains to Equal-Weight : PT $68.00 $BGNE Morgan Stanley Maintains to Overweight : PT $241.00 $PRNB SVB Leerink Maintains to Outperform : PT $112.00 $RCUS SVB Leerink Maintains to Outperform : PT $44.00 $TMO announces that it has developed a new blood test for the transplant community that detects anti-SARS-CoV-2 antibodies. The assay, to be sold under the One Lambda brand as LABScreen COVID Plus, detects multiple distinct antibodies and fragments enabling a more complete characterization of the immune response to COVID-19. It will be available for research use only this month. $JNJ Covid-19 vaccine trial will test a single dose. Scheduled to start in September. 60 K patients |
return to message board, top of board |